TOP NIKE ANALYSTS LOVE RECENT NUMBERS Wednesday 12/23/2015

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz fitzkarz #39685
TOP NIKE ANALYSTS LOVE RECENT NUMBERS
Wednesday 12/23/2015 10:54 AM ET - S&P Capital IQ's Views and News

Shares of Nike Inc (NYSE: NKE) have appreciated 38.51 percent year to date, touching a high of $134.33 on November 27. Several top analysts recommended buying the stock, while one preferred to remain on the sidelines. The analysts believe that "Santa came early" for Nike this year, with the company posting strong EPS and futures growth for 2Q16. Santa Came Early Macquarie's Laurent Vasilescu has reiterated an Outperform rating on the company, while raising the price target from $150 to $155. Nike posted more than 20 percent EPS growth once again for 2Q16, with "very impressive" futures of 20 percent. North American revenues rose in the high single digits, while futures grew 14 percent. Vasilescu mentioned that the 60 bps year on year improvement in the EBIT margin during 2Q was encouraging. Management has guided to a 50 bps gross margin decline for 3Q16, in order to clear inventories. Internationally also the company continued its strong momentum, with futures growth in the double digits, on a constant currency basis. "Particular strength came from China and Western Europe," Vasilescu said, where gross and EBIT margins improved, despite FX headwinds. The FY16 EPS estimate was raised from $4.43 to $4.46. Continued Momentum Brean Capital's Eric Tracy maintained a Buy rating on the company, while raising the price target from $144 to $147. "We remain constructive on shares of NKE, with 2Q showing continued momentum across all geographies and most product categories," Tracy stated. Tracy believes that visibility into the company's fundamentals continue to be high, with innovation giving Nike a competitive edge and supporting pricing. Structural drivers for the company, such as manufacturing and supply chain, continue to drive accretive growth. The company reported its EPS and futures growth well ahead of the estimates and consensus, although revenue was in line with the estimates and below the consensus. Excess inventory in the domestic markets are expected to weigh on gross margins in the near term, with the 3Q gross margin guided down 50 bps year on year. According to the Brean Capital report, "While these headwinds should be more than offset by strong int'l growth, we also believe clearance efforts will create opp to highlight new products, with the innovation pipeline accelerating into mega-sporting events in CY16." Apparel ASP growth is also expected to accelerate, with Nike's "best-in-class R&D program catalyzing premium product position." The EPS estimates for 3Q, 4Q, FY16 and FY17 have been raised to reflect the 2Q beat and robust futures growth. Among Best S&P 500 Stocks Morgan Stanley's Jay Sole has maintained an Overweight rating on Nike, with a price target of $139. According to Sole, "Nike's solid 2Q16 report confirmed the long-term story is intact and the global athletic wear trend continues." Sole also mentioned that the Nike has been among the S&P 500's best stocks year to date and that further outperformance was expected in 2016. Sole believes that the 2Q results illustrate that the company is capitalizing on various opportunities, with China revenue increasing 28 percent and online sales growing almost 50 percent year on year. The 20 percent increase in global futures suggests that the company continues to gain significant market shares across all major geographies. "Nike's second quarter also demonstrated the power of its business model and the ways it can offset weakness in one area with strength in another to exceed," the Morgan Stanley report added. Incredible Futures Growth Canaccord Genuity's Camilo Lyon maintained a Hold rating on the company, with a price target of $132. Although the 2Q EPS beat expectations, Lyon noted that the "beat was less robust than in prior quarters," and "largely driven by a lower tax rate, a push-out of expenses and slightly better gross margin, partly offset by lower revenue, less other income and higher shares outstanding." The significantly higher than estimated global futures suggests that demand remained strong across the company's key geographies, with continued strength in North America, which Lyon believes bodes well for athletic retailers. Western Europe and China witnessed sequential acceleration, implying strong demand across various categories. "Despite volatile macro-economic conditions, China is experiencing tremendous growth as NKE continues to reap the early benefits of its reset strategy." the Canaccord report said. Lyon expects the impressive DTC growth to continue going forward, with sportswear likely to the key to sustained ASP growth. Running Fast Enough DA Davidson's Andrew Burns maintained a Buy rating on the company, while raising the price target from $145 to $156. Most companies have been highlighting the highly challenging retail environment, particularly in the US. Against this backdrop, Nike's success across footwear, apparel, DTC and all geographic regions "is impressive," Burns said. The company has delivered the third consecutive quarter of Futures order growth acceleration, which underlines the brand's growing popularity. Although excess inventory in North America is expected to exert pressure on F3Q gross margin, Burns pointed out that the full year outlook "implies a quick snap back in F4Q margin performance." "Longer-term, we remain confident in NKE's ability to expand gross margin via pricing power, operational efficiencies and DTC outgrowth," the analyst added. Elsewhere On The Street Jefferies analysts maintained a Buy rating, while raising the price target from $144 to $147. Citi analysts maintained a Buy rating, while raising the price target from $142 to $154. Buckingham Research analysts maintained a Buy rating, while raising the price target from $140 to $150. Acquire Media
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

McKay Brothers Enhances Fastest Routes for Market Data

Updated Category News Views 68

Breaking Down McKay Brothers' Latest Maneuver Yeah, the financial market isn't just numbers and screens—it's about moving those numbers faster than a cheetah chasing prey. McKay Brothers knows this game inside and out, and they're laying down new wires, or rather, wireless, to make sure they've got the quickest routes in the room. Let me tell you, they're throwing money...

Continue Reading
Shield HealthCare Expands Access for Astiva Members

Updated Category News Views 76

Opening Up New Avenues for Health Care Here's a nugget from the healthcare sector that's worth chewing on. Shield HealthCare has just inked a deal with Astiva Health that opens the floodgates for eligible members in Southern California to access medical supplies through Shield's extensive network. It's a big move that aims to make health management a tad easier for folks...

Continue Reading
Torchy's Tacos Reintroduces Nookies: Fan Favorite Returns

Updated Category News Views 78

A Sweet Return to the Menu In the wild world of fast-casual dining, bringing back a beloved menu item is like striking gold. Torchy's Tacos is doing just that by reintroducing their legendary Nookies—fried chocolate chip cookie dough bites that have been a crowd favorite since 2008. After a two-year hiatus, these treats are back, complete with a cinnamon-sugar twist to...

Continue Reading
CopperWood Senior Living Revives Historic Campus

Updated Category News Views 86

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

Continue Reading
ZYNLONTA's Japanese Push: ADC Therapeutics Gains Traction

Updated Category News Views 69

ADC Therapeutics Eyes Japan with ZYNLONTA Bet These days, everyone seems to have their eyes on the Far East, and ADC Therapeutics is no exception. They're making a strategic leap by letting their budding blockbuster ZYNLONTA make waves in Japan. With the fresh file submitted for approval, it looks like they're hoping to capture market ground that could pay off big time...

Continue Reading
LUNGevity's Every Breath Forward Drives Awareness and Action

Updated Category News Views 125

A Bold New Campaign for Lung Cancer Awareness Amidst the hustle and bustle of daily life, a solemn campaign rises, taking aim at lung cancer's staggering toll on lives. LUNGevity Foundation is rolling out its initiative, Every Breath Forward?, this November, spotlighting unity and action during Lung Cancer Awareness Month. Forget the red carpets and flashy...

Continue Reading
NIIT Expands with Bluewater: AI-Led Workforce Revolution

Updated Category News Views 63

Big Moves in Talent Transformation There's a shakeup in the learning space, folks, and it's all about building a more AI-driven future. Today we're dissecting how NIIT Learning Systems Limited, a name that rings a bell in global managed learning, just snapped up Bluewater Learning. Not just a small fry acquisition, oh no—this one's got some meaty implications, tallying...

Continue Reading
Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

Updated Category News Views 70

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Continue Reading
Eli Lilly Shifts Portfolio Focus, Boosts Outlook

Updated Category News Views 97

Strong Quarter Signals Strategic Pivots Board a runaway train, folks, 'cause Eli Lilly (NYSE:LLY) is steaming ahead with third-quarter results that'll make any investor sit up and take notice. Revenue's up 39% to a hearty $24.4 billion, with Mounjaro and Zepbound doing some serious lifting. This ain't just small potatoes; it's full-on farm territory. Financial Peaks and...

Continue Reading
Duolingo Lawsuit Looms Over Securities Allegations

Updated Category News Views 26

Duolingo Lawsuit: A New Headache for Investors Seems like every time you blink, another tech darling is getting dragged to court, and now it's Duolingo's turn to face the music. They're locked in a class action lawsuit food-fight over violations of the Securities Exchange Act of 1934, specifically, §§10(b) and 20(a), and Rule 10b-5. The Core of Allegations Against...

Continue Reading

Top 5 Most Recently Viewed Articles

Hancock Whitney Corporation Set to Unveil Q4 2024 Results

Updated Category News Views 238

Hancock Whitney Corporation to Announce Q4 2024 Financial Results Hancock Whitney Corporation (Nasdaq: HWC) is scheduled to reveal its financial performance for the fourth quarter of 2024. The announcement will take place on a Tuesday afternoon, specifically after the market closes, a time when stakeholders eagerly await insights into the company's latest earnings report....

Continue Reading
Transform Your Journey to Parenthood with Faith and Support

Updated Category News Views 126

Faithful Fertility Collective's New Program to Encourage Conception Madison, Wisconsin – Faithful Fertility Collective, a pioneer in holistic and faith-oriented fertility coaching, has exciting news to share! The organization is launching its latest program, titled "Miracle in the Making." This innovative initiative spans over six months and aims to help couples realize...

Continue Reading
How to Determine Responsibility for Slip and Fall Injuries in Clearwater, FL

Updated Category Personal Finance Views 53

A fall on someone else’s property can raise many questions beyond the injury itself. A damaged walkway, missing warning sign, or unsafe condition may hold important clues about what caused the accident. Determining responsibility requires looking at the details surrounding the incident, including the condition of the property and the actions taken before the fall. A...

Continue Reading
Usio's Upcoming Investor Conferences: What to Expect

Updated Category News Views 102

Usio's Upcoming Investor Conferences: What to Expect Usio, Inc. (Nasdaq: USIO), a pioneer in cloud-based electronic payment solutions, is gearing up for a series of notable investor conferences. These events present an excellent opportunity for investors to understand the company’s vision and progress. The conferences will be a mix of virtual and in-person engagements,...

Continue Reading
Omnia Exterior Solutions Partners with James & Whitney for Growth

Updated Category News Views 312

Omnia Exterior Solutions Partners with James & Whitney Omnia Exterior Solutions™ has recently unveiled an exciting partnership with James & Whitney Company, a leading name in residential roofing and exterior services across the Northeast. This collaboration marks a significant milestone, being the eighth addition to the Omnia family this year and the 11th since the...

Continue Reading